CNSX:AGRA

Agraflora Organics International Competitors

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume580,821 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Agraflora Organics International (CNSX:AGRA) Vs. RIV, WLLW, LABS, KHRN, DN, and META

Should you be buying AGRA stock or one of its competitors? Companies in the industry of "drug manufacturers—specialty & generic" are considered alternatives and competitors to Agraflora Organics International, including RIV Capital (RIV), Willow Biosciences Inc. (WLLW.TO) (WLLW), MediPharm Labs (LABS), Khiron Life Sciences (KHRN), Delta 9 Cannabis (DN), and Meta Growth (META).

RIV Capital (TSE:RIV) and Agraflora Organics International (CNSX:AGRA) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, risk, profitability, valuation and earnings.

Valuation and Earnings

This table compares RIV Capital and Agraflora Organics International's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
RIV CapitalC$15.44 million18.85$-106,223,568.00C($0.76)-2.74
Agraflora Organics InternationalN/AN/AN/AN/AN/A

Agraflora Organics International has lower revenue, but higher earnings than RIV Capital.

Profitability

This table compares RIV Capital and Agraflora Organics International's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
RIV CapitalN/AN/AN/A
Agraflora Organics InternationalN/AN/AN/A

Analyst Ratings

This is a summary of recent recommendations and price targets for RIV Capital and Agraflora Organics International, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
RIV Capital01002.00
Agraflora Organics International00103.00

RIV Capital presently has a consensus target price of C$4.00, suggesting a potential upside of 92.31%. Agraflora Organics International has a consensus target price of $0.08, suggesting a potential upside of ∞. Given Agraflora Organics International's stronger consensus rating and higher probable upside, analysts clearly believe Agraflora Organics International is more favorable than RIV Capital.

Summary

Agraflora Organics International beats RIV Capital on 3 of the 4 factors compared between the two stocks.

Willow Biosciences Inc. (WLLW.TO) (TSE:WLLW) and Agraflora Organics International (CNSX:AGRA) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, risk, profitability, valuation and earnings.

Valuation and Earnings

This table compares Willow Biosciences Inc. (WLLW.TO) and Agraflora Organics International's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Willow Biosciences Inc. (WLLW.TO)C$10,000.0016,148.11$-51,032,952.00C($0.41)-3.16
Agraflora Organics InternationalN/AN/AN/AN/AN/A

Agraflora Organics International has lower revenue, but higher earnings than Willow Biosciences Inc. (WLLW.TO).

Profitability

This table compares Willow Biosciences Inc. (WLLW.TO) and Agraflora Organics International's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Willow Biosciences Inc. (WLLW.TO)N/AN/AN/A
Agraflora Organics InternationalN/AN/AN/A

Analyst Ratings

This is a summary of recent recommendations and price targets for Willow Biosciences Inc. (WLLW.TO) and Agraflora Organics International, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Willow Biosciences Inc. (WLLW.TO)0000N/A
Agraflora Organics International00103.00

Willow Biosciences Inc. (WLLW.TO) presently has a consensus target price of C$2.25, suggesting a potential upside of 71.76%. Agraflora Organics International has a consensus target price of $0.08, suggesting a potential upside of ∞. Given Agraflora Organics International's higher probable upside, analysts clearly believe Agraflora Organics International is more favorable than Willow Biosciences Inc. (WLLW.TO).

Summary

Agraflora Organics International beats Willow Biosciences Inc. (WLLW.TO) on 2 of the 3 factors compared between the two stocks.

MediPharm Labs (TSE:LABS) and Agraflora Organics International (CNSX:AGRA) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, risk, profitability, valuation and earnings.

Valuation and Earnings

This table compares MediPharm Labs and Agraflora Organics International's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MediPharm LabsC$36.01 million3.37$-123,815,040.00C($0.48)-0.98
Agraflora Organics InternationalN/AN/AN/AN/AN/A

Agraflora Organics International has lower revenue, but higher earnings than MediPharm Labs.

Profitability

This table compares MediPharm Labs and Agraflora Organics International's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
MediPharm LabsN/AN/AN/A
Agraflora Organics InternationalN/AN/AN/A

Analyst Ratings

This is a summary of recent recommendations and price targets for MediPharm Labs and Agraflora Organics International, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
MediPharm Labs02023.00
Agraflora Organics International00103.00

MediPharm Labs presently has a consensus target price of C$1.53, suggesting a potential upside of 225.53%. Agraflora Organics International has a consensus target price of $0.08, suggesting a potential upside of ∞. Given Agraflora Organics International's higher probable upside, analysts clearly believe Agraflora Organics International is more favorable than MediPharm Labs.

Khiron Life Sciences (CVE:KHRN) and Agraflora Organics International (CNSX:AGRA) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, risk, profitability, valuation and earnings.

Valuation and Earnings

This table compares Khiron Life Sciences and Agraflora Organics International's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Khiron Life SciencesC$8.01 million9.75$-39,493,921.00C($0.26)-1.98
Agraflora Organics InternationalN/AN/AN/AN/AN/A

Agraflora Organics International has lower revenue, but higher earnings than Khiron Life Sciences.

Profitability

This table compares Khiron Life Sciences and Agraflora Organics International's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Khiron Life SciencesN/AN/AN/A
Agraflora Organics InternationalN/AN/AN/A

Analyst Ratings

This is a summary of recent recommendations and price targets for Khiron Life Sciences and Agraflora Organics International, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Khiron Life Sciences0000N/A
Agraflora Organics International00103.00

Khiron Life Sciences presently has a consensus target price of C$1.20, suggesting a potential upside of 130.77%. Agraflora Organics International has a consensus target price of $0.08, suggesting a potential upside of ∞. Given Agraflora Organics International's higher probable upside, analysts clearly believe Agraflora Organics International is more favorable than Khiron Life Sciences.

Summary

Agraflora Organics International beats Khiron Life Sciences on 2 of the 3 factors compared between the two stocks.

Delta 9 Cannabis (TSE:DN) and Agraflora Organics International (CNSX:AGRA) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, dividends, analyst recommendations, risk, profitability and earnings.

Earnings & Valuation

This table compares Delta 9 Cannabis and Agraflora Organics International's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Delta 9 CannabisC$52.05 million1.12$-7,346,808.00C($0.07)-7.92
Agraflora Organics InternationalN/AN/AN/AN/AN/A

Agraflora Organics International has lower revenue, but higher earnings than Delta 9 Cannabis.

Profitability

This table compares Delta 9 Cannabis and Agraflora Organics International's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Delta 9 CannabisN/AN/AN/A
Agraflora Organics InternationalN/AN/AN/A

Analyst Recommendations

This is a summary of recent ratings and target prices for Delta 9 Cannabis and Agraflora Organics International, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Delta 9 Cannabis00014.00
Agraflora Organics International00103.00

Delta 9 Cannabis presently has a consensus target price of C$1.10, suggesting a potential upside of 92.98%. Agraflora Organics International has a consensus target price of $0.08, suggesting a potential upside of ∞. Given Agraflora Organics International's higher probable upside, analysts clearly believe Agraflora Organics International is more favorable than Delta 9 Cannabis.

Summary

Delta 9 Cannabis beats Agraflora Organics International on 3 of the 5 factors compared between the two stocks.

Agraflora Organics International (CNSX:AGRA) and Meta Growth (CVE:META) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, dividends, profitability, earnings, risk, analyst recommendations and institutional ownership.

Profitability

This table compares Agraflora Organics International and Meta Growth's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Agraflora Organics InternationalN/AN/AN/A
Meta GrowthN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Agraflora Organics International and Meta Growth, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Agraflora Organics International00103.00
Meta Growth0000N/A

Agraflora Organics International currently has a consensus price target of $0.08, suggesting a potential upside of ∞. Given Agraflora Organics International's higher probable upside, equities analysts plainly believe Agraflora Organics International is more favorable than Meta Growth.

Valuation and Earnings

This table compares Agraflora Organics International and Meta Growth's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Agraflora Organics InternationalN/AN/AN/AN/AN/A
Meta GrowthC$60.96 million0.54C$-50,412,840.00C($0.21)-0.66

Agraflora Organics International has higher earnings, but lower revenue than Meta Growth.

Summary

Agraflora Organics International beats Meta Growth on 2 of the 3 factors compared between the two stocks.


Agraflora Organics International Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
RIV
RIV Capital
0.8$2.08flatC$291.10 millionC$15.44 million-2.74Gap Up
WLLW
Willow Biosciences Inc. (WLLW.TO)
1.1$1.31flatC$161.48 millionC$10,000.00-3.16
LABS
MediPharm Labs
1.4$0.47flatC$121.24 millionC$36.01 million-0.98
KHRN
Khiron Life Sciences
0.9$0.52flatC$67.34 millionC$8.01 million-1.98
DN
Delta 9 Cannabis
1.4$0.57flatC$58.16 millionC$52.05 million-7.92
META
Meta Growth
0.8$0.14flatC$36.69 millionC$60.96 million-0.66News Coverage
Gap Up
NRTH
48North Cannabis
0.7$0.16flatC$36.44 millionC$17.36 million-0.59Gap Down
CSI
(CSI)
0.6N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
BAMM
28896
0.5N/AN/A$0.00N/A0.00High Trading Volume
ATT
Abattis Bioceuticals
0.5N/AN/AC$0.00N/A0.00Gap Down
GRIN
Grindrod Shipping
1.7N/AN/A$0.00N/A0.00High Trading Volume
IMCC
IM Cannabis
0.0N/AN/A$0.00N/A0.00High Trading Volume
PULL
Mind Cure Health
1.7N/AN/A$0.00N/A0.00High Trading Volume
SPR
Spirit AeroSystems
0.5N/AN/A$0.00N/A0.00High Trading Volume
News Coverage
BUZZ
VanEck Vectors Social Sentiment ETF
1.0N/AN/A$0.00N/A0.00High Trading Volume
VIDA
Vidaroo
0.5N/AN/A$0.00N/A0.00High Trading Volume
This page was last updated on 4/19/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.